NASDAQ:ALMS - Nasdaq - US0223071020 - Common Stock - Currency: USD
2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | ||||
---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | |||
Operating Expenses | 300.75M | 158.17M | 113.85M | |||
Research and Development | 265.55M | 137.68M | 101.30M | |||
Selling, General, and Administrative Expenses | 35.20M | 20.50M | 12.55M | |||
Operating Income | -300.75M | -158.17M | -113.85M | |||
Interest Income/Expense | 6.61M | 3.25M | 1.99M | |||
Other Income/Expense | -93.00K | -68.00K | -72.00K | |||
Income Before Taxes | -294.23M | -154.99M | -111.93M | |||
Net Income | -294.23M | -154.99M | -111.93M | |||
EBITDA | -297.60M | -156.89M | -113.60M | |||
Per Share Data | ||||||
EPS Diluted Total Ops | -5.41 | -2.99 | -2.16 | |||
Statistics |
All data in USD